Education
About Us
Working with TipRanks
Follow Us
BioNTech SE (DE:22UA)
XETRA:22UA
Earnings Data
Report Date
Mar 10, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.48Last Year’s EPS
1.08Same Quarter Last Year
Strong Buy
Based on 17 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
BioNTech showed strong progress in its oncology programs and financial position, highlighted by increased revenue and strategic advancements. However, challenges include significant financial losses and delays in product submissions due to regulatory discussions.Company Guidance
Increased Revenue and Financial Guidance
Total revenues for Q3 2025 were EUR 1.519 billion, an increase from EUR 1.245 billion in Q3 2024. The company also raised its revenue guidance for 2025 to $2.6 billion to $2.8 billion, primarily due to recognition of USD 700 million from the BMS collaboration.
Advancements in Oncology Programs
Significant progress in the Pumitamig program with enrollment in two global registrational trials in lung cancer, and initiation of the TNBC Phase III. Over a dozen signal-seeking studies progressed, and the company is on track for potential product launches before the end of the decade.
Strong Financial Position
BioNTech's cash, cash equivalents, and security investments totaled EUR 16.7 billion at the end of Q3 2025, ensuring resources and flexibility to fund oncology transition.
DE:22UA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:22UA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 04, 2025 | €92.05 | €97.05 | +5.43% |
May 05, 2025 | €92.60 | €89.70 | -3.13% |
Mar 10, 2025 | €101.60 | €98.05 | -3.49% |
Nov 04, 2024 | €102.40 | €102.20 | -0.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BioNTech SE (DE:22UA) report earnings?
BioNTech SE (DE:22UA) is schdueled to report earning on Mar 10, 2026, Before Open (Confirmed).
What is BioNTech SE (DE:22UA) earnings time?
BioNTech SE (DE:22UA) earnings time is at Mar 10, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of BioNTech SE stock?
The P/E ratio of BioNTech SE is N/A.
What is DE:22UA EPS forecast?
DE:22UA EPS forecast for the fiscal quarter 2025 (Q4) is -0.48.
